Biomedical Technology

GRANT TECHNOLOGY (HK) CO., LIMITED

🌍 Official Website 🏢 HKSTP Source
68 Potential

Decision Maker

Mr. William Cheng
william@gtech.hk
+852 25621982
Unit 333, 3/Fl., Building 16W, Phase 3 Hong Kong Science Park Shatin
Raw Description
Since 2014, Grant Technology has invested in the research and development of a medical device for anti-microbial susceptibility testing; a patent was filed in January 2016 and approved, and the product launch is scheduled for early 2017. The future of the company remains in R&D. In 2015, we invested in an ITC funded research project on a new anti-influenza drug as an industry partner with the University of Hong Kong; patents have been filed and approved. The in-vivo tests have been completed, and phase I clinical trial is expected to begin in 2018. As one of the few biotech companies established and based in the Hong Kong Science Park, we strongly believe these new developments will take our company to new heights.

Strategic Analysis

Executive Brief

Grant Technology (HK) Co., Limited is a specialized biotechnology firm based in the Hong Kong Science Park, primarily focused on the intersection of medical diagnostics and pharmaceutical R&D. Their flagship portfolio includes a proprietary medical device for rapid Anti-Microbial Susceptibility Testing (AST) and the development of novel anti-influenza therapeutics. Their business model is driven by intellectual property (IP) generation and clinical translation of biomedical engineering solutions.

Strategic Fit & Lead Score

Lead Score: 68/100

Why this Score? While Grant Technology is a biotech firm rather than a semiconductor or optics house, their AST medical device represents a high-value opportunity for Boron Doped Diamond (BDD) integration. Standard electrochemical sensors in diagnostics often suffer from "electrode fouling" (bio-interference) and narrow potential windows. 6C’s BDD technology provides the widest electrochemical window of any material, which is critical for the sensitivity required in rapid microbial detection. Their location in the HK Science Park also makes them an ideal candidate for R&D Consulting as they scale their diagnostic hardware.

6C Solutions Proposal

Application Area 6C Solution Technical Value Prop
AST Diagnostic Sensors BDD Electrodes Boron Doped Diamond offers a wide potential window (>3V) and low capacitive background noise, allowing for the detection of ultra-low concentrations of bacterial metabolites or drug markers without electrode degradation.
Bio-Sensing Reliability Direct Diamond Coating 6C can provide MPCVD diamond coatings for sensor surfaces to prevent bio-fouling. Diamond is inherently bio-inert, meaning bacteria won't "stick" to the sensor, maintaining accuracy over multiple tests.
Drug Analysis (R&D) SCD Optical Windows For their anti-influenza drug R&D, if using Raman Spectroscopy or IR for molecular characterization, 6C’s Single Crystal Diamond (SCD) provides >99% transparency across UV-to-Far IR, enabling ultra-precise chemical signatures.
In-house Prototyping Custom MPCVD Reactor As an R&D-heavy firm, Grant Tech could benefit from a desktop-scale 6C reactor to develop proprietary diamond-based biosensors in-house, securing their IP chain.
High-Purity Processing H2 Generators (9N) For their pharmaceutical lab environments requiring ultra-high purity atmospheres for drug synthesis or sensitive chemical vapor processes.

Engagement Hooks

  • Technical Question: "For your AST medical device, are you encountering limitations in sensor sensitivity or electrode longevity due to the corrosive nature of biological samples? Our BDD electrodes offer a virtually indestructible alternative to traditional carbon or gold electrodes with a significantly higher signal-to-noise ratio."
  • Value Statement: "6C can accelerate Grant Technology’s diagnostic precision by integrating bio-inert, electrochemical-grade diamond components that eliminate sensor fouling and reduce time-to-result for anti-microbial testing."